- Filings
-
Holdings
-
Transcripts
- ETFs
-
Insider
- Institutional
- Shorts
- Profile
-
Financials
MicroAlgo (MLGO) Financial statements
Company Profile
| Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | ||
|---|---|---|---|---|---|---|
| Total Revenue | ||||||
| Cost of Revenue | ||||||
| Gross Profit | ||||||
| Gross Profit Margin (%) | ||||||
| R&D Expense | ||||||
| SG&A Expense | ||||||
| Total Operating Expenses | ||||||
| Operating Income or Loss | ||||||
| Operating Margin (%) | ||||||
| Interest Expense | ||||||
| Total Other Income/Expenses | ||||||
| Income Before Tax | ||||||
| Income Tax Expense | ||||||
| Income from Continuing Ops. | ||||||
| Net Income | ||||||
| Net Profit Margin (%) | ||||||
| Net Income Available to Common Shareholders | ||||||
| Basic EPS | ||||||
| Diluted EPS | ||||||
| Basic Average Shares | ||||||
| Diluted Average Shares |
| Dec 2024 | Dec 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||||||||
| Cost of Revenue | |||||||||||||
| Gross Profit | |||||||||||||
| Gross Profit Margin (%) | |||||||||||||
| R&D Expense | |||||||||||||
| SG&A Expense | |||||||||||||
| Total Operating Expenses | |||||||||||||
| Operating Income or Loss | |||||||||||||
| Operating Margin (%) | |||||||||||||
| Interest Expense | |||||||||||||
| Total Other Income/Expenses | |||||||||||||
| Income Before Tax | |||||||||||||
| Income Tax Expense | |||||||||||||
| Income from Continuing Ops. | |||||||||||||
| Net Income | |||||||||||||
| Net Profit Margin (%) | |||||||||||||
| Net Income Available to Common Shareholders | |||||||||||||
| Basic EPS | |||||||||||||
| Diluted EPS | |||||||||||||
| Basic Average Shares | |||||||||||||
| Diluted Average Shares |
| Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | ||
|---|---|---|---|---|---|---|
| Current Assets | ||||||
| Cash & Cash Equivalents | ||||||
| Marketable Securities | ||||||
| Receivables | ||||||
| Inventories | ||||||
| Other Current Assets | ||||||
| Total Current Assets | ||||||
| Non-Current Assets | ||||||
| Marketable Securities | ||||||
| PPE Net | ||||||
| Intangibles inc. Goodwill | ||||||
| Other Non-Current Assets | ||||||
| Total Non-Current Assets | ||||||
| Total Assets | ||||||
| Current Liabilities | ||||||
| Accounts Payable | ||||||
| Deferred Revenues | ||||||
| Debt, Current | ||||||
| Accrued Liabilities | ||||||
| Other Current Liabilities | ||||||
| Total Current Liabilities | ||||||
| Non-Current Liabilities | ||||||
| Deferred Revenues | ||||||
| Debt, Non-Current | ||||||
| Other Non-Current Liabilities | ||||||
| Total Non-Current Liabilities | ||||||
| Total Liabilities | ||||||
| Shareholders' Equity | ||||||
| Common Stock | ||||||
| Additional Paid-In Capital | ||||||
| Retained Earnings | ||||||
| Other Shareholders' Equity | ||||||
| Total Shareholders' Equity | ||||||
| Total Liabilities & Shareholders' Equity |
| Dec 2024 | Dec 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | |||||||||||||
| Cash & Cash Equivalents | |||||||||||||
| Marketable Securities | |||||||||||||
| Receivables | |||||||||||||
| Inventories | |||||||||||||
| Other Current Assets | |||||||||||||
| Total Current Assets | |||||||||||||
| Non-Current Assets | |||||||||||||
| Marketable Securities | |||||||||||||
| PPE Net | |||||||||||||
| Intangibles inc. Goodwill | |||||||||||||
| Other Non-Current Assets | |||||||||||||
| Total Non-Current Assets | |||||||||||||
| Total Assets | |||||||||||||
| Current Liabilities | |||||||||||||
| Accounts Payable | |||||||||||||
| Deferred Revenues | |||||||||||||
| Debt, Current | |||||||||||||
| Accrued Liabilities | |||||||||||||
| Other Current Liabilities | |||||||||||||
| Total Current Liabilities | |||||||||||||
| Non-Current Liabilities | |||||||||||||
| Deferred Revenues | |||||||||||||
| Debt, Non-Current | |||||||||||||
| Other Non-Current Liabilities | |||||||||||||
| Total Non-Current Liabilities | |||||||||||||
| Total Liabilities | |||||||||||||
| Shareholders' Equity | |||||||||||||
| Common Stock | |||||||||||||
| Additional Paid-In Capital | |||||||||||||
| Retained Earnings | |||||||||||||
| Other Shareholders' Equity | |||||||||||||
| Total Shareholders' Equity | |||||||||||||
| Total Liabilities & Shareholders' Equity |
| Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | ||
|---|---|---|---|---|---|---|
| Cash Flows from Operating Activities | ||||||
| Net Income | ||||||
| Depreciation & Amortization | ||||||
| Deferred Income Taxes | ||||||
| Stock Based Compensation | ||||||
| Accounts Receivable | ||||||
| Inventory | ||||||
| Accounts Payable | ||||||
| Deferred Revenue | ||||||
| Other Non-Cash | ||||||
| Operating Cash Flow | ||||||
| Cash Flows from Investing Activities | ||||||
| PPE Investments | ||||||
| Net Acquisitions | ||||||
| Purchase of Investments | ||||||
| Sale of Investments | ||||||
| Other Investing Activity | ||||||
| Investing Cash Flow | ||||||
| Cash Flows from Financing Activities | ||||||
| Debt Issued | ||||||
| Proceeds from Debt Repayment | ||||||
| Debt Repayment | ||||||
| Proceeds from Sale of Equity | ||||||
| Equity Repurchased | ||||||
| Dividend Paid | ||||||
| Other Financing Activity | ||||||
| Financing Cash Flow | ||||||
| Cash Position | ||||||
| Beginning Cash Position | ||||||
| End Cash Position | ||||||
| Change in Cash | ||||||
| Free Cash Flow | ||||||
| Operating Cash Flow | ||||||
| Capital Expenditure | ||||||
| Free Cash Flow |
| Dec 2024 | Dec 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||||||||||
| Net Income | |||||||||||||
| Depreciation & Amortization | |||||||||||||
| Deferred Income Taxes | |||||||||||||
| Stock Based Compensation | |||||||||||||
| Accounts Receivable | |||||||||||||
| Inventory | |||||||||||||
| Accounts Payable | |||||||||||||
| Deferred Revenue | |||||||||||||
| Other Non-Cash | |||||||||||||
| Operating Cash Flow | |||||||||||||
| Cash Flows from Investing Activities | |||||||||||||
| PPE Investments | |||||||||||||
| Net Acquisitions | |||||||||||||
| Purchase of Investments | |||||||||||||
| Sale of Investments | |||||||||||||
| Other Investing Activity | |||||||||||||
| Investing Cash Flow | |||||||||||||
| Cash Flows from Financing Activities | |||||||||||||
| Debt Issued | |||||||||||||
| Proceeds from Debt Repayment | |||||||||||||
| Debt Repayment | |||||||||||||
| Proceeds from Sale of Equity | |||||||||||||
| Equity Repurchased | |||||||||||||
| Dividend Paid | |||||||||||||
| Other Financing Activity | |||||||||||||
| Financing Cash Flow | |||||||||||||
| Cash Position | |||||||||||||
| Beginning Cash Position | |||||||||||||
| End Cash Position | |||||||||||||
| Change in Cash | |||||||||||||
| Free Cash Flow | |||||||||||||
| Operating Cash Flow | |||||||||||||
| Capital Expenditure | |||||||||||||
| Free Cash Flow |